Israel signs deal with US drug firm for potential COVID-19 vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ israel-signs-deal-us-drug-firm-potential-covid19-vaccine
Israel has reported 19,783 novel coronavirus cases and 303 deaths.

Israel has consented to an arrangement with Moderna Inc for the future acquisition of its potential COVID-19 immunization, Prime Minister Benjamin Netanyahu said on Wednesday.

The Cambridge, Massachusetts-based biotech firm a week ago affirmed intends to begin a preliminary of 30,000 volunteers of its eagerly awaited immunization in July as the organization enters the last phases of testing.

It is one of a few antibodies being tried the world over as drugmakers race to battle the pandemic. There are as of now no affirmed medicines or immunizations for COVID-19.

"Israel has marked with the organization Moderna a course of action that will permit us to purchase immunizations," Netanyahu stated, as indicated by an announcement from his office.

"The organization is propelling its turn of events, they guarantee they can accomplish it by the center of one year from now, we trust that they succeed," he said.

Money related subtleties were not uncovered.

Netanyahu included that Israel would proceed with its own endeavors to build up a COVID-19 immunization through the Israel Institute for Biological Research.

Israel - with a populace of 9 million - has announced 19,783 novel coronavirus cases and 303 passings. It has seen a spike in new diseases since reviving schools, cafés, and numerous organizations a month ago.

Different nations, including France, Germany, and Italy, have marked flexibly manages British drugmaker AstraZeneca for its potential COVID-19 immunization.

Tags : #Israel #COVID-19 #Signs #Drug

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026